| Literature DB >> 33330519 |
Eling D de Bruin1,2, Heiner Baur3, Yvonne Brülhart3, Eefje Luijckx3, Timo Hinrichs4, Slavko Rogan3.
Abstract
Purpose: Physical and mental functions allow classifying older adults as "Go-Go" (independent functioning); "Slow-Go" (in need of care with a slight handicap); and "No-Go" (in need of care with severe functional limitation). The latter group exhibits reduced exercise tolerance. More recently technology-based motor-cognitive types of training services emerged as a possible training service. This study examined the use of technology including stochastic resonance whole-body vibration and Exergame-dance training for motor-cognitive training in care home dwelling adults.Entities:
Keywords: aging; executive functions; exergame; frail adults; long term care; motor-cognitive training; physical performance; whole-body vibration
Year: 2020 PMID: 33330519 PMCID: PMC7734185 DOI: 10.3389/fmed.2020.507155
Source DB: PubMed Journal: Front Med (Lausanne) ISSN: 2296-858X
Figure 1Study flow chart of the allocation and the participants throughout the study. SR-WBV, stochastic resonance whole-body vibration; 4W, after 4 weeks; 8W: after 8 weeks; 12W: after 12 weeks.
Figure 2Zeptor med® device. Example of the vibration training on the Zeptor med® device with two feet on separate platforms.
Figure 3Step Game. Example for the virtual dance training with the Step Game beamed on the wall.
Figure 4Dance pad. Example of the virtual dance training on the dance pad.
Figure 5Picture of the Aktiv Tramp® (Frei Swiss AG).
Demographic and anthropometric characteristics of the participants.
| Sex (female/male) | 5/4 | 5/3 | |
| Age (years, mean, ± SD) | 86.1 ± 5.9 | 90.3 ± 5.9 | 0.29 |
| Age (range) | 79–98 | 80–95 | |
| Height (m, mean, ± SD) | 1.66 ± 0.04 | 1.62 ± 0.06 | 0.10 |
| Weight (kg, mean, ± SD) | 68.4 ± 15.2 | 65.1 ± 10.3 | 0.34 |
| MMSE | 26.6 (21.75–30.00) | 28.0 (25.00–29.00) | 0.86 |
| SPPB | 3.5 (2.75–5.25) | 4.0 (2.00–5.00) | 0.83 |
IG, intervention group; SG, sham group; SD, standard deviation; MMSE, Mini Mental State Examination Test; SPPB, Short Physical Performance Battery.
SPPB ANOVA with repeated measurements (ranks) between-group main effects and group-by-time interaction.
| SPPB total score (main effects) | 1.80 | 7.79 | 0.003 | 0.64 |
| SPPB total score (interaction effects) | 0.76 | 3.28 | 0.055 | 0.43 |
| SPPB chair rises (main effects) | 0.65 | 7.86 | 0.003 | 0.65 |
| SPPB chair rises (interaction effects) | 0.51 | 4.58 | 0.021 | 0.51 |
| SPPB gait speed (main effects) | 0.27 | 1.62 | 0.232 | 0.27 |
| SPPB gait speed (interaction effects) | 0.22 | 1.25 | 0.332 | 0.22 |
| SPPB balance (main effects) | 1.45 | 6.30 | 0.007 | 0.59 |
| SPPB balance (interaction effects) | 0.35 | 1.55 | 0.248 | 0.26 |
SPPB, Short Physical Performance Battery;
significant difference p < 0.05, ES, effect size (η.
SPPB post-hoc analysis at BASE, 4W, 8W, and follow up.
| SPPB total score IG ( | 3.9 ± 1.5 | 0.729 | 5.0 ± 1.5 | 0.143 | 6.7 ± 1.6 | 0.005 | 6.9 ± 1.6 | 0.018 |
| SPPB total score SG ( | 3.6 ± 1.5 | 3.9 ± 1.6 | 4.1 ± 1.6 | 0.423 | 4.4 ± 1.8 | 0.368 | ||
| SPPB chair rises IG ( | 0.9 ± 1.1 | 0.915 | 0.9 ± 1.1 | 0.540 | 1.7 ± 1.3 | 0.236 | 1.9 ± 0.9 | 0.165 |
| SPPB chair rises SG ( | 0.8 ± 0.5 | 1.1 ± 1.0 | 1.0 ± 0.8 | 0.109 | 1.1 ± 1.0 | 0.141 | ||
| SPPB gait speed IG ( | 1.3 ± 0.7 | 0.765 | 1.6 ± 0.7 | 0.507 | 2.3 ± 0.8 | 0.080 | 2.0 ± 0.7 | 0.033 |
| SPPB gait speed SG ( | 1.3 ± 0.9 | 1.3 ± 0.7 | 1.6 ± 0.9 | 0.162 | 1.1 ± 0.8 | 0.262 | ||
| SPPB balance IG ( | 1.7 ± 0.9 | 0.870 | 2.5 ± 0.7 | 0.004 | 2.7 ± 0.8 | 0.021 | 2.9 ± 0.3 | 0.168 |
| SPPB balance SG ( | 1.6 ± 0.9 | 1.4 ± 0.5 | 1.6 ± 0.9 | 0.329 | 2.1 ± 1.1 | 0.188 |
IG, intervention group; SG, sham group; SPPB, Short Physical Performance Battery; BASE, baseline measurements; 4W, after 4 weeks; 8W, after 8 weeks;
significant difference after Bonferroni adjustment p < 0.0125; ES: effect size (η.
ANOVA with repeated measurements (ranks) between-group main effects and group-by-time interaction for the secondary outcomes TMT A & B and FES-I.
| TMT A (main effects) | 0.43 | 1.85 | 0.189 | 0.299 |
| TMT A (interaction effects) | 0.07 | 0.32 | 0.814 | 0.068 |
| TMT B (main effects) | 0.01 | 0.02 | 0.995 | 0.005 |
| TMT B (interaction effects) | 1.58 | 6.84 | 0.005 | 0.612 |
| FES-I (main effects) | 0.001 | 0.004 | 1.000 | 0.001 |
| FES-I (interaction effects) | 0.287 | 1.244 | 0.334 | 0.22 |
TMT, Trail Making Test; FES-I, Falls Efficacy Scale-International;
significant difference p < 0.05; ES, effect size (η.
Post-hoc analysis at BASE, 4W, 8W, and follow up for the secondary outcomes TMT A & B and FES-I.
| TMT A IG (s), ( | 71.9 ± 38.6 | 0.336 | 69.8 ± 32.43 | 0.054 | 73.8 ± 44.6 | 0.248 | 68.7 ± 44.9 | 0.700 |
| TMT A SG (s), ( | 111.7 ± 79.0 | 124.5 ± 75.63 | 116.0 ± 83.8 | 0.157 | 66.5 ± 17.8 | 0.116 | ||
| TMT B IG (s), ( | 199.3 ± 55.0 | 0.594 | 206.0 ± 53.3 | 0.239 | 164.3 ± 44.5 | 0.002 | 157.5± 27.6 | 0.001 |
| TMT B SG (s), ( | 197.7 ± 33.1 | 209.7 ± 48.5 | 231.1 ± 46.5 | 0.779 | 233.1 ± 0.0 | 0.827 | ||
| TMT B-A IG | 132.6 ±31.2 | 0.174 | 151.7 ± 31.2 | 0.040 | 124.4 ± 38.4 | 0.621 | 117.7 ± 72.0 | 0.45 |
| TMT B-A SG | 67.3 ± 87.9 | 93.0 ± 54.7 | 148.5 ± 86.8 | 0.023 | 150.3 ± 82.1 | 0.049 | ||
| FES-I IG | 34.2 ± 10.3 | 0.961 | 22.8 ± 4.4 | 0.627 | 22.2 ± 4.9 | 0.439 | 20.7 ± 3.2 | 0.244 |
| FES-I SG | 35.6 ± 14.9 | 28.4 ± 16.6 | 31.1 ± 18.2 | 0.169 | 34.4 ± 19.1 | 0.190 |
Results are expressed as mean and standard deviation (±). IG, intervention group; SG, sham group; TMT A & B, Trail Making Test A & B; FES-I, Falls Efficacy Scale—International; BASE, baseline measurements; 4W, after 4 weeks; 8W, after 8 weeks; s, seconds;
significant difference after Bonferroni adjustment p < 0.0125; ES, effect size (η.